Rheumatology NewsMany children who present to headache clinics have joint hypermobilityOctober 25, 2019PediatricsLupus & Connective Tissue Diseases
Rheumatology NewsNewly described lung disorder strikes children with systemic juvenile idiopathic arthritisOctober 10, 2019Pediatrics
Rheumatology NewsFDA approves rituximab to treat children with rare vasculitisSeptember 30, 2019PediatricsLupus & Connective Tissue DiseasesMixed Topics
Rheumatology NewsAnakinra treatment for pediatric ‘cytokine storms’: Does one size fit all?September 25, 2019Pediatrics
Rheumatology NewsACR looks for continued growth in awareness of rheumatic diseases with latest annual campaignSeptember 20, 2019PediatricsRheumatoid ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsJuvenile dermatomyositis derails growth and pubertal developmentSeptember 18, 2019Pediatrics
Rheumatology NewsTwo uveitis treatment options yield similar successSeptember 10, 2019Ankylosing spondylitisSpondyloarthropathiesPediatrics
Rheumatology NewsBisphosphonates improve BMD in pediatric rheumatic diseaseAugust 14, 2019OsteoporosisPediatrics
Rheumatology NewsPROMIS tools provide useful data for managing rheumatology patientsAugust 12, 2019Psoriatic ArthritisRheumatoid ArthritisOsteoarthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisSpondyloarthropathiesPediatrics
Rheumatology NewsHadlima approved as fourth adalimumab biosimilar in U.S.July 23, 2019Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathiesPediatrics
Rheumatology NewsMechanism does not matter for second-line biologic choice in JIAJuly 19, 2019Pediatrics
Rheumatology NewsTocilizumab linked to refractory uveitis improvements in some JIA patientsJuly 12, 2019Pediatrics
Rheumatology NewsEmapalumab produces major responses in macrophage activation syndromeJuly 9, 2019Pediatrics
Rheumatology NewsEfforts toward producing CNO/CRMO classification criteria show first resultsJune 20, 2019Pediatrics